Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Psychiatry
•
Child & Adolescent Psychiatry
•
General Psychiatry
When would you consider transdermal treatments for ADHD?
Related Questions
What pharmacological management to you consider in patients with Autism Spectrum Disorder whose primary behavior is aggression?
When do you use SNRIs or norepinephrine reuptake inhibitors (e.g., atomoxetine) for the treatment of ADHD?
How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?
How do you approach neuromodulation in postpartum depression?
What pharmacologic therapy, if any, do you recommend for treatment of borderline personality disorder?
What medications are safe to use to treat major depression and/or anxiety in a patient with closed-angle glaucoma?
Do you believe that buspirone is ineffective in patients who are previously treated with benzodiazepines?
How reliable do you find it to make the diagnosis of bipolar disorder based on a patient report of prior symptoms or questionnaire and not the actual observation of hypo/mania on the exam?
How do you approach treatment-refractory schizophrenia which has not responded to multiple antipsychotic trials including clozapine?
What do you do when a patient with postpartum depression at risk for harming their children stops treatment against medical advice?
